{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:39:26Z","timestamp":1761237566619},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.3816\/clm.2004.n.006","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:22Z","timestamp":1221095422000},"page":"19-28","source":"Crossref","is-referenced-by-count":17,"title":["Molecular Diagnosis and Outcome Prediction in Diffuse Large B-Cell Lymphoma and Other Subtypes of Lymphoma"],"prefix":"10.3816","volume":"5","author":[{"given":"Karen","family":"Dybkaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guimei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.3816\/CLM.2004.n.006_bib1","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"key":"10.3816\/CLM.2004.n.006_bib2","first-page":"57","article-title":"Histological classification and occurrence of Hodgkin's disease [in German]","volume":"15","author":"Lennert","year":"1974","journal-title":"Internist (Berl)"},{"key":"10.3816\/CLM.2004.n.006_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.3816\/CLM.2004.n.006_bib4","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical usage","volume":"49","author":"The Non-Hodgkin's Lymphoma Pathologic Classification Project","year":"1982","journal-title":"Cancer"},{"key":"10.3816\/CLM.2004.n.006_bib5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib6","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Diffuse large B-cell lymphoma","author":"Gatter","year":"2001"},{"key":"10.3816\/CLM.2004.n.006_bib7","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non- Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2004.n.006_bib8","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"171","article-title":"Diffuse large B-cell lymphoma","author":"Gatter","year":"2001"},{"key":"10.3816\/CLM.2004.n.006_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001622-200109000-00003","article-title":"Diffuse large cell lymphoma","volume":"13","author":"Coiffier","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.3816\/CLM.2004.n.006_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large Bcell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.3816\/CLM.2004.n.006_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/sqb.1999.64.71","article-title":"The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes","volume":"64","author":"Alizadeh","year":"1999","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.3816\/CLM.2004.n.006_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2004.n.006_bib13","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.180316097","article-title":"Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas","volume":"97","author":"Lossos","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2004.n.006_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2004.n.006_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood.V99.1.282","article-title":"Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays","volume":"99","author":"Husson","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)63284-1","article-title":"BCL2 translocation defines a subset of DLBCL with germinal center B-cell-like gene expression profiles and preferential expression of a set of genes","author":"Iqbal","year":"2004","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2004.n.006_bib18","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2004.n.006_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.3816\/CLM.2004.n.006_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(02)00714-3","article-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand?","volume":"3","author":"Barth","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.3816\/CLM.2004.n.006_bib21","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"175","article-title":"Mediastinal (thymic) large B-cell lymphoma","author":"Banks","year":"2001"},{"key":"10.3816\/CLM.2004.n.006_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2004.n.006_bib23","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large Bcell lymphomas and shares features with classical Hodgkin's lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib24","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib25","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"key":"10.3816\/CLM.2004.n.006_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","article-title":"bcl-1, t(11;14), and mantle cell-derived lymphomas","volume":"78","author":"Raffeld","year":"1991","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib27","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2004.n.006_bib28","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.0831102100","article-title":"Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma","volume":"100","author":"Fang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2004.n.006_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.3816\/CLM.2004.n.006_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(00)81519-6","article-title":"Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1","volume":"98","author":"Harbour","year":"1999","journal-title":"Cell"},{"key":"10.3816\/CLM.2004.n.006_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"10.3816\/CLM.2004.n.006_bib32","first-page":"2409","article-title":"BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas","volume":"61","author":"Bea","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2004.n.006_bib33","first-page":"4398","article-title":"Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells","volume":"62","author":"Ek","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2004.n.006_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.3816\/CLM.2004.n.006_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V98.3.787","article-title":"Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray","volume":"98","author":"Hofmann","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib36","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"162","article-title":"Follicular lymphoma","author":"Nathwani","year":"2001"},{"key":"10.3816\/CLM.2004.n.006_bib37","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/j.1460-2075.1995.tb00251.x","article-title":"Loss of p53 function through PAXmediated transcriptional repression","volume":"14","author":"Stuart","year":"1995","journal-title":"EMBO J"},{"key":"10.3816\/CLM.2004.n.006_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0161-5890(99)00071-1","article-title":"Overexpression of the Helix- Loop-Helix protein Id2 blocks T cell development at multiple stages","volume":"36","author":"Morrow","year":"1999","journal-title":"Mol Immunol"},{"key":"10.3816\/CLM.2004.n.006_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","article-title":"Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation","volume":"15","author":"Ruuls","year":"2001","journal-title":"Immunity"},{"key":"10.3816\/CLM.2004.n.006_bib40","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1073\/pnas.0437875100","article-title":"Variation in gene expression patterns in follicular lymphoma and the response to rituximab","volume":"100","author":"Bohen","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2004.n.006_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated lowgrade non-Hodgkin's lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2004.n.006_bib43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib44","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V96.2.635","article-title":"Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5\u2032 noncoding regulatory region of the BCL-6 gene","volume":"96","author":"Lossos","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib46","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1182\/blood.V88.10.3937.bloodjournal88103937","article-title":"Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene","volume":"88","author":"Matolcsy","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib47","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib48","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib49","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2004.n.006_bib50","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","article-title":"Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations","volume":"101","author":"Martinez-Climent","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib51","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1137463100","article-title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38- mitogen-activated protein kinase as a target for therapy","volume":"100","author":"Elenitoba-Johnson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2004.n.006_bib52","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma (SLL), marginal zone B-cell lymphoma (MZL), mantle cell lymphoma (MCL) exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"104","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2004.n.006_bib53","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:21Z","timestamp":1588918161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511700525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1526965511700525"],"URL":"https:\/\/doi.org\/10.3816\/clm.2004.n.006","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}